Human monkeypox - After 40 years, an unintended consequence of smallpox eradication.
Human monkeypox - After 40 years, an unintended consequence of smallpox eradication.
复制标题
DOI:
10.1016/j.vaccine.2020.04.062
复制
发表时间:
2020-07-14
期刊:
影响因子:
5.5
通讯作者:
Wapling A
中科院分区:
文献类型:
--
作者:
Simpson K;Heymann D;Brown CS;Edmunds WJ;Elsgaard J;Fine P;Hochrein H;Hoff NA;Green A;Ihekweazu C;Jones TC;Lule S;Maclennan J;McCollum A;Mühlemann B;Nightingale E;Ogoina D;Ogunleye A;Petersen B;Powell J;Quantick O;Rimoin AW;Ulaeato D;Wapling A
Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation of routine smallpox vaccination in most countries. It is estimated that over 70% of the world’s population is no longer protected against smallpox, and through cross-immunity, to closely related orthopox viruses such as monkeypox. Monkeypox is now a re-emerging disease. Monkeypox is endemic in as yet unconfirmed animal reservoirs in sub-Saharan Africa, while its human epidemiology appears to be changing. Monkeypox in small animals imported from Ghana as exotic pets was at the origin of an outbreak of human monkeypox in the USA in 2003. Travellers infected in Nigeria were at the origin of monkeypox cases in the UK in 2018 and 2019, Israel in 2018 and Singapore in2019. Together with sporadic reports of human infections with other orthopox viruses, these facts invite speculation that emergent or re-emergent human monkeypox might fill the epidemiological niche vacated by smallpox. An ad-hoc and unofficial group of interested experts met to consider these issues at Chatham House, London in June 2019, in order to review available data and identify monkeypox-related research gaps. understanding of zoonotic hosts, reservoirs and vectors. risks associated with transmission. full description of the clinical spectrum and the natural history of infection including an estimation of the prevalence of monkeypox specific antibodies in humans living in areas of emergence. Gaps identified by the experts included:The experts further agreed on the need for a better understanding of the genomic evolution and changing epidemiology of orthopox viruses, the usefulness of in-field genomic diagnostics, and the best disease control strategies, including the possibility of vaccination with new generation non-replicating smallpox vaccines and treatment with recently developed antivirals.
登录
查看更多内容
影响因子:
3.7
作者:
Hutson, Christina L.;Gallardo-Romero, Nadia;Damon, Inger K.
通讯作者:
Damon, Inger K.
影响因子:
3.8
作者:
Falendysz EA;Lopera JG;Doty JB;Nakazawa Y;Crill C;Lorenzsonn F;Kalemba LN;Ronderos MD;Mejia A;Malekani JM;Karem K;Carroll DS;Osorio JE;Rocke TE
通讯作者:
Rocke TE
DOI:
10.4269/ajtmh.2007.77.1150
发表时间:
2007-12-01
影响因子:
3.3
作者:
Lederman, Edith R.;Reynolds, Mary G.;Damon, Inger K.
通讯作者:
Damon, Inger K.
DOI:
10.3390/v10050252
发表时间:
2018-05-12
期刊:
Viruses
影响因子:
--
作者:
Gao J;Gigante C;Khmaladze E;Liu P;Tang S;Wilkins K;Zhao K;Davidson W;Nakazawa Y;Maghlakelidze G;Geleishvili M;Kokhreidze M;Carroll DS;Emerson G;Li Y
通讯作者:
Li Y
影响因子:
3.3
作者:
Li, Daniel;Wilkins, Kimberly;Reynolds, Mary G.
通讯作者:
Reynolds, Mary G.